Amn Healthcare Services INC
Market Movers (8-K)
NYSE
AMN Healthcare reported strong first quarter 2026 financial results, with revenue and adjusted EBITDA surpassing guidance due to robust performance in key staffing segments.
Better than expected
NYSE
AMN Healthcare Services, Inc. announced that its shareholders approved an amendment to the 2025 Equity Plan, increasing the number of authorized shares and ratifying the appointment of KPMG LLP.
NYSE
AMN Healthcare Services, Inc. announced the retirement of R. Jeffrey Harris from its Board of Directors and the intent to nominate Eric Palmer as his successor.
NYSE
AMN Healthcare Services, Inc. presented its strategic vision and financial outlook at the J.P. Morgan Healthcare Conference, highlighting a return to growth in key segments and leveraging technology to address healthcare labor shortages.
NYSE
AMN Healthcare Services, Inc. adopted amended and restated by-laws to enhance corporate governance, streamline shareholder meeting procedures, and refine director nomination processes.
NYSE
AMN Healthcare reported third quarter 2025 financial results exceeding guidance, driven by strong staffing order rebound and strategic debt refinancing.
Capital raise
Better than expected
Quarterly Earnings (10-Q)
NYSE
AMN Healthcare reported an 8% revenue decline in Q3 2025, with significant goodwill and intangible asset impairments leading to a net loss for the nine months, despite a Q3 net income increase.
Worse than expected
Capital raise
NYSE
AMN Healthcare Services reported a significant net loss of $116.2 million in Q2 2025, driven by widespread revenue declines across segments and substantial goodwill and long-lived asset impairment charges.
Worse than expected
NYSE
AMN Healthcare Services' Q1 2025 revenue decreased by 16% year-over-year to $689.5 million, reflecting a decline in demand for travel nurse staffing and other workforce solutions.
Worse than expected
NYSE
10-Q: AMN Healthcare Services Reports Q3 2024 Results: Revenue Declines Amid Shifting Market Dynamics
AMN Healthcare Services experienced a 19% year-over-year revenue decrease in Q3 2024, driven by reduced demand in travel nursing and other staffing segments.
Worse than expected
NYSE
10-Q: AMN Healthcare Services Reports Q2 2024 Results: Revenue Declines Amid Shifting Market Dynamics
AMN Healthcare Services experienced a 25% year-over-year revenue decrease in the second quarter of 2024, primarily due to reduced demand in its nurse and allied solutions segment.
Worse than expected
NYSE
10-Q: AMN Healthcare Services Reports Q1 2024 Results: Revenue Declines Amid Shifting Market Dynamics
AMN Healthcare Services experienced a 27% year-over-year decrease in revenue for the first quarter of 2024, primarily due to reduced demand in its nurse and allied solutions segment.
Worse than expected
Annual Reports (10-K)
NYSE
AMN Healthcare Services reports a decrease in revenue and a net loss for 2024, driven by market shifts and a goodwill impairment charge.
Worse than expected
NYSE
AMN Healthcare's 10-K filing details executive equity plans, including restricted stock unit agreements and a compensation recoupment policy.
Insider Trading (Form 4)
NYSE
Daphne E. Jones, a Director at AMN Healthcare Services, Inc., has filed an amended Form 4 to correct previous ownership reporting and to reflect new equity awards.
NYSE
Mark G. Foletta, a director at AMN Healthcare Services Inc., sold a total of 3,681 shares of common stock under pre-arranged 10b5-1 trading plans.
NYSE
Eric P. Palmer, a Director at AMN Healthcare Services Inc., received a grant of 8,304 Restricted Stock Units (RSUs) on May 1, 2026.
NYSE
Director James H. Hinton acquired 8,304 Restricted Stock Units (RSUs) in AMN Healthcare Services Inc. on May 1, 2026, as part of the company's 2025 Equity Plan.
NYSE
Teri G. Fontenot, a Director at AMN Healthcare Services Inc., was granted 8,304 Restricted Stock Units (RSUs) on May 1, 2026, with vesting scheduled for May 1, 2027, or the 2027 Annual Meeting of Shareholders.
NYSE
R. Jeffrey Harris, a Director at AMN Healthcare Services Inc., reported transactions involving the acquisition of common stock upon the vesting of Restricted Stock Units (RSUs) on May 1, 2026.
Proxy Statements (Def-14A)
NYSE
AMN Healthcare Services, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on May 2, 2025, outlining key proposals for shareholder voting.
NYSE
AMN Healthcare addresses a challenging 2024 with strategic shifts towards technology and cost management, positioning for future growth amid industry stabilization.
Worse than expected
NYSE
AMN Healthcare Services, Inc. announces its 2024 Annual Meeting of Shareholders to be held virtually on April 19, 2024, with key voting items including the election of directors, executive compensation, and ratification of KPMG LLP as the independent accounting firm.
NYSE
DEF 14A: AMN Healthcare Aims for Sustainable Growth with Focus on Innovation and Financial Discipline
AMN Healthcare's proxy statement highlights the company's strategic focus on innovation, financial discipline, and delivering a unique value proposition in a normalizing healthcare environment.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.07% of AMN Healthcare Services Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in AMN Healthcare Services Inc. following an internal realignment.
NYSE
Millennium Management and affiliated entities filed an amended Schedule 13G for AMN Healthcare Services, Inc., disclosing their beneficial ownership.
NYSE
The Vanguard Group updated its beneficial ownership in AMN Healthcare Services Inc. to 9.46% and disclosed an internal realignment affecting its reporting structure.
NYSE
Millennium Management LLC and affiliated entities have reported a 6.4% beneficial ownership stake in AMN Healthcare Services, Inc. common stock.
NYSE
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 0.0% beneficial ownership in AMN Healthcare Services Inc. as of September 30, 2025, indicating a significant reduction or divestment of their previous stake.